A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PM
Long Form : paromomycin
No. Year Title Co-occurring Abbreviation
2019 Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis. MTC
2019 Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. EE, MCS
2019 Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis. CS, EE, MCS
2018 Chemotherapeutics of visceral leishmaniasis: present and future developments. L-AmB, VL
2018 Combination of paromomycin plus human anti-TNF-alpha antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions. Ab, CL
2018 Treatment outcomes of visceral leishmaniasis in Ethiopia from 2001 to 2017: a systematic review and meta-analysis. L-AmB, SSG, VL
2017 Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis. CL, CQ
2017 Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme. AE, DNDi, IM, MSF, PSUR, PV, SAE, SSG, VL
2016 A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study. OR, PKDL, SSG, VL
10  2015 An update on pharmacotherapy for leishmaniasis. CL, L-AmB, VL
11  2014 Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis. PKDL, VL
12  2014 Topical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulation. CL, LCL
13  2013 Bioanalytical method development, pharmacokinetics, and toxicity studies of paromomycin and paromomycin loaded in albumin microspheres. PM-MS
14  2013 Paromomycin-loaded albumin microspheres: efficacy and stability studies. MS, PM-MS, VL
15  2011 Characterization, thermal stability studies, and analytical method development of Paromomycin for formulation development. ---
16  2011 Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation. MS
17  2007 Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. CI, KA, OR, SSG
18  2006 Chemotherapy in the treatment and control of leishmaniasis. ---
19  2003 [Recovery of facultatives and anaerobes from frozen specimens with a polymicrobial nature]. BBE, PEA, VM
20  2000 A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Sb, VL
21  1987 Altered sensitivity of protein synthesis to paromomycin in extracts from aging human diploid fibroblasts. ---
22  1981 Does the capacity of ribosomes to control translation fidelity change with age? Leu, Phe